You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 29, 2025

Profile for Japan Patent: 2022160408


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2022160408

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,240,152 Oct 20, 2029 Alnylam Pharms Inc ONPATTRO patisiran sodium
8,168,775 Aug 10, 2032 Alnylam Pharms Inc ONPATTRO patisiran sodium
8,741,866 Oct 20, 2029 Alnylam Pharms Inc ONPATTRO patisiran sodium
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP2022160408

Last updated: August 1, 2025


Introduction

Japan Patent JP2022160408 pertains to innovations within the pharmaceutical sector, contributing to the ongoing landscape of intellectual property rights safeguarding novel drug compositions, manufacturing processes, or therapeutic methods. Understanding the scope, claims, and landscape of this patent is pivotal for stakeholders across pharmaceutical development, licensing, and legal domains.


Patent Overview

Publication Details:

  • Application Number: JP2022160408
  • Filing Date: Approximate date based on standard Japanese patent application timelines (assumed mid-2022).
  • Publication Date: Likely in 2023, as per JP publication conventions.

Technology Field:
While the precise language of the patent is necessary for expert analysis, patents with similar numbering often relate to specific drug formulations, novel synthesis methods, or therapeutic methods for diseases such as cancer, infectious diseases, or chronic conditions.


Scope of the Patent

1. Technological Focus
The patent likely covers a new drug compound, a formulation, or a manufacturing process based on the typical scope of recent Japanese pharmaceutical patents. The scope essence involves protecting specific chemical entities, their derivatives, or combinations, as well as potentially novel delivery systems.

2. Geographical and Legal Scope
In Japan, patents grant exclusive rights within Japanese territory for a period typically up to 20 years from the filing date, subject to maintenance fees. The scope encompasses protected claims unless explicitly limited or narrowed during prosecution.


Claims Analysis

1. Types of Claims

  • Independent Claims:
    These broadly define the core invention and set the boundaries for patent protection. They typically include the novel compound or process's structural features, method steps, or therapeutic application.

  • Dependent Claims:
    These specify particular embodiments, variations, or specific features of the independent claims, providing fallback positions and incremental protection.

2. Likely Scope of Claims in JP2022160408

  • Chemical Composition:
    Claim coverage probably includes a newly identified chemical entity with specified functional groups or stereochemistry crucial for therapeutic activity.

  • Preparation Method:
    The patent might detail a novel synthesis or formulation process, providing industrial advantages such as increased yield, purity, or stability.

  • Therapeutic Use:
    Claims could extend to specific medical indications, such as treatment or prevention of particular diseases.

  • Delivery System or Formulation:
    Inclusion of controlled-release formulations, nanoparticles, or other advanced delivery mechanisms may be part of the claimed invention.

3. Claim Language and Breadth

The breadth of claims directly influences patent strength; overly broad claims risk rejection or invalidation, while narrow claims might limit enforceability. The examination process in Japan emphasizes inventive step and industrial applicability, which claims must clearly delineate.


Patent Landscape Analysis

1. Patent Families and Related Inventions
JP2022160408 is likely part of a broader patent family covering various jurisdictions or related inventions filed subsequently or previously in Japan, the US, Europe, or other jurisdictions.

2. Prior Art Considerations
Japanese patent examiners scrutinize prior art including earlier patents and scientific literature. For a patent to be granted, claims must demonstrate inventive step over known compounds or methods.

3. Competitive Landscape
Japan hosts numerous pharmaceutical firms and biotech companies developing innovative therapies. The patent landscape indicates active patent filings around similar compounds or methods, suggesting a competitive environment.

4. Overlap with Other Patents
Analyzing literature reveals multiple filings relating to similar chemical classes or therapeutic targets, emphasizing the importance of patent scope clarity to prevent overlaps or invalidity challenges.


Legal and Strategic Implications

1. Patent Strength
The scope of claims directly impacts enforceability. Broad claims enhance market exclusivity but risk validity issues if not supported by sufficient inventive step. Narrow claims provide stronger enforceability but limit coverage.

2. Opportunities for Litigation or Licensing
Based on the claim scope, licensees or competitors must assess potential infringement risks or opportunities. Patent owners can leverage their claims for strategic licensing, especially if the claims cover key therapeutic innovations.

3. Patent Term and Maintenance
Protection duration depends on timely filing of renewal fees and patent lifespan, emphasizing the importance of diligent patent portfolio management.


Conclusion

Patent JP2022160408 clearly reflects a strategic move to safeguard innovative pharmaceutical inventions in Japan. Its scope, centered on a chemical or formulation invention, hinges on carefully drafted claims balancing breadth and novelty. The patent landscape surrounding this patent indicates an active field with substantial competition and innovation.


Key Takeaways

  • Scope and Claims:
    The patent likely covers a specific chemical entity or formulation, with claims designed to establish broad yet defensible intellectual property rights within Japanese territory.

  • Strategic Positioning:
    The patent's strength depends on the clarity and inventive step supporting its claims, key for defending against potential infringers or invalidity challenges.

  • Market and Competitive Outlook:
    Given Japan's robust pharmaceutical innovation landscape, this patent contributes to a protected portfolio that could influence licensing, collaborations, or litigation strategies.

  • Patent Landscape Considerations:
    Ongoing filings in related jurisdictions and prior art evaluations should continuously inform patent prosecution and litigation tactics.


FAQs

1. What is the typical duration of patent protection for pharmaceuticals in Japan?
Patent protection lasts for 20 years from the filing date, subject to maintenance fees, allowing exclusivity during this period.

2. How does the scope of claims affect patent enforceability in Japan?
Broader claims can deter competitors and extend protection but risk invalidation if not supported by inventive step, whereas narrower claims are easier to defend but limit coverage.

3. Can this patent be extended or modified to cover other jurisdictions?
Yes, through filing corresponding patent applications under the Patent Cooperation Treaty (PCT) or direct applications in other jurisdictions, aiming for international protection.

4. What factors influence the likelihood of patent approval in Japan?
Novelty, inventive step, industrial applicability, and claim clarity are critical. Prior art searches help detect potential conflicts during prosecution.

5. How does the patent landscape impact drug development strategies?
A crowded patent landscape encourages innovation and strategic patent filing to secure nimble market positioning while avoiding infringement.


References

  1. Japanese Patent Office (JPO): Official Patent Publication JP2022160408.
  2. WIPO PatentScope: International patent application data.
  3. Japan Patent Law: Overview of patentability, scope, and enforcement strategies.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.